Skip to content
2023 DRUG TREND REPORT

ERx Logo with Tagline - A Navitus Solution-01



High-Touch, High-Quality Service for Clients and Members

ERx-specially designed-01-1Our in-house solution for 3000 lives and fewer, EpiphanyRx™, delivers with innovative programs that manage costs and keep member needs at the forefront. In 2023 EpiphanyRx rose to to the challenges that come for plan sponsors when a member receives a rare disease diagnosis and delivered on their commitment to clients and members.

An automotive manufacturing company with 3000 employees recently faced the complications associated with prescription care for the diagnosis of one employee with hypophosphatasia (HPP), a rare genetic condition that causes abnormal development of bones and teeth.ERx-190 savings-4 

EpiphanyRx was at the automative manufacturing company’s side to deliver high-touch, high-quality service that saved dollars and bolstered care. To better manage cost, the client implemented the QALYiQ program that specifically targets high-cost medications. This intentional approach included:

  • Hands-on support to help the affected member access funding through several auxiliary programs
  • Outreach to both the member and the prescriber by a specialized team
  • Implementation of dose optimization for additional savings

The program and intervention strategies saved the plan $190,000. The member received the therapy they needed for this rare condition. The approach reduced the financial strains and positively impacted member health. 

Download Your Free Copy of the 2023 Drug Trend Executive Summary

An in-depth analysis of trends and drug pipeline insights
 
shutterstock_2197444629_download image